31 ThorssonVGibbsDLBrownSDWolfDBortoneDSOu YangT-Het al
[2] Since then, several other GLP-1 agonists have been developed and approved for clinical use, including liraglutide (Victoza), dulaglutide (Trulicity), semaglutide (Ozempic and Wegovy), and Tirzepatide (Mounjaro and Zepbound)
Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P et al
While there is no universally set BMI for prescribing Ozempic for weight loss, it is generally reserved for those classified as overweight or obese, especially in the presence of other health issues
For media inquiries, please contact External Relations at [email protected].
Essential protocols to guarantee the integrity and bioactivity of your research peptides